Smith & Nephew plc (LON:SN) Receives GBX 1,381.33 Consensus Target Price from Analysts

Shares of Smith & Nephew plc (LON:SN) have received a consensus rating of “Hold” from the six analysts that are covering the company, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is GBX 1,381.33.

A number of analysts recently issued reports on SN shares. Berenberg Bank reissued a “hold” rating and set a GBX 1,300 price objective on shares of Smith & Nephew in a report on Friday, January 23rd. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Smith & Nephew in a research report on Friday, November 7th. Royal Bank Of Canada downgraded shares of Smith & Nephew to a “sector perform” rating and lowered their price target for the stock from GBX 1,700 to GBX 1,350 in a report on Wednesday, December 17th. Citigroup boosted their price objective on shares of Smith & Nephew from GBX 1,450 to GBX 1,600 and gave the company a “buy” rating in a research note on Friday, October 31st. Finally, Panmure Gordon reiterated a “hold” rating and issued a GBX 1,200 target price on shares of Smith & Nephew in a research note on Tuesday, December 9th.

Insider Activity

In related news, insider Deepak Nath sold 1,240 shares of Smith & Nephew stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of GBX 1,257, for a total transaction of £15,586.80. Company insiders own 0.19% of the company’s stock.

Smith & Nephew Price Performance

LON:SN opened at GBX 1,278.50 on Tuesday. The stock’s 50-day moving average is GBX 1,234.56 and its two-hundred day moving average is GBX 1,291.55. The company has a current ratio of 2.51, a quick ratio of 0.84 and a debt-to-equity ratio of 70.22. The stock has a market capitalization of £14.02 billion, a P/E ratio of 46.03, a P/E/G ratio of 0.46 and a beta of 0.62.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.